16
Wed, Oct
56 New Articles

New Ethics & Compliance Director at Astellas Pharma Turkey

New Ethics & Compliance Director at Astellas Pharma Turkey

Turkey
Typography

Altug Ozgun has confirmed that in January 2017 he left the Sandoz to become the Ethics & Compliance Director at Astellas Pharma, Inc.

Astellas Pharma is a Japanese pharmaceutical company, created on April 1, 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co. It is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu. Its franchise areas are urology, immunology (transplantation), dermatology, cardiology, and infectious disease. Priority areas for R&D are infectious diseases, diabetes, gastrointestinal diseases, oncology, and diseases of the central nervous system. According to Ozgun, Astellas is currently re-organizing its Ethics & Compliance organization worldwide “to be one of the top tier pharma companies in the compliance area.”

Ozgun has been working as an in-house legal and compliance counsel in the healthcare/life sciences sector for more than 12 years. He started his career as a practicing lawyer in the Ozgun law firm and then continued in multinational companies such as Eastpharma (Deva), then switched from pharma to medical devices in Beckman Coulter (a Danaher company). He continued his career as a Head Legal & Compliance in Sandoz (a Novartis division). He is a graduate of Marmara University and holds an LL.M. from Marmara University European Union Law Institute. He is a member of Istanbul Bar Association.

Ozgun told CEE Legal Matters, “I’m really enthusiastic about this move. I decided to concentrate on Ethics and Compliance and wanted to challenge myself in a young and dynamic organization. Working in a Japanese company with the ‘kaizen’ mindset was the attractive point to decide and I believe this shift will enable me to make a valuable contribution.”

Estonian Knowledge Partner

COBALT is closely integrated alliance of top-tier law offices in Estonia, Latvia, Lithuania and Belarus, making us one of the largest law firms in the Baltic market. 

COBALT is a trusted partner for daily matters and complex large-scale transactions and disputes. The firm’s broad spectrum of expertise and established position as the market leader give a comprehensive basis for providing advice on special areas of business law.

We advise top international and regional businesses, financial institutions, state and local governments, and the region’s most promising start-ups. We offer leading-edge solutions in key industry sectors: Consumer Products, Trade & Distribution, Real Estate & Construction, Pharmaceuticals & Healthcare, Energy & Utilities, Communications, Media & Technologies, Financial Services, Transport & Logistics.

COBALT has been named Baltic Law Firm of the Year 6 times. We were recognized as the Most Innovative Law Firm of the Year 2019 in the Baltics at the IFLR European Awards in London. COBALT also won CEE Legal Matters Deal of the Year Award for Estonia, Latvia, and Lithuania, as well as the overall Baltic Deal of the Year, at the 2019 CEE Legal Matters Awards. We have received multiple awards from the Chambers Europe, IFLR, The Lawyer and Mergermarket and we are regularly listed amongst the top performing M&A legal advisors in the Bloomberg, Thomson Reuters and Mergermarket deal tables

More information on Cobalt can be found at www.cobalt.legal

All News about Cobalt can be found here.

 

Our Latest Issue